IRIS
RECCHIUTI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.277
AS - Asia 2.040
EU - Europa 1.848
SA - Sud America 214
AF - Africa 49
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.182
SG - Singapore 888
CN - Cina 485
IT - Italia 345
IE - Irlanda 250
SE - Svezia 222
RU - Federazione Russa 221
VN - Vietnam 221
UA - Ucraina 186
BR - Brasile 166
GB - Regno Unito 161
TR - Turchia 147
DE - Germania 138
IN - India 111
FR - Francia 106
FI - Finlandia 56
CA - Canada 51
AT - Austria 46
HK - Hong Kong 42
PL - Polonia 29
AR - Argentina 24
MX - Messico 24
JP - Giappone 23
BD - Bangladesh 20
KR - Corea 19
NL - Olanda 19
ZA - Sudafrica 16
ES - Italia 15
BE - Belgio 14
EG - Egitto 13
BZ - Belize 12
IQ - Iraq 12
AU - Australia 9
IR - Iran 9
PK - Pakistan 9
IL - Israele 8
LT - Lituania 8
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
ID - Indonesia 6
CO - Colombia 5
KE - Kenya 5
PH - Filippine 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CL - Cile 4
EC - Ecuador 4
MA - Marocco 4
PT - Portogallo 4
TW - Taiwan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
DZ - Algeria 3
GE - Georgia 3
HR - Croazia 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
AL - Albania 2
BO - Bolivia 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
JO - Giordania 2
LB - Libano 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EU - Europa 1
FJ - Figi 1
GA - Gabon 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LY - Libia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PR - Porto Rico 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 7.439
Salva come PNG Salva come JPEG
Città #
Singapore 680
Chandler 366
San Jose 346
Ashburn 283
Dublin 248
Jacksonville 229
Dallas 130
Beijing 129
New York 128
Princeton 110
Dearborn 94
Southend 88
Izmir 77
Ann Arbor 74
Santa Clara 70
Los Angeles 69
The Dalles 69
Ho Chi Minh City 68
Wilmington 66
Nanjing 62
Boardman 56
Pescara 55
Hanoi 52
Chieti 43
Altamura 41
Council Bluffs 39
Rome 37
Houston 35
Vienna 35
Tongling 34
Woodbridge 32
Cambridge 28
Hong Kong 28
Montreal 27
Hefei 26
Redondo Beach 26
Washington 25
Buffalo 24
Augusta 23
Munich 23
Nuremberg 23
Warsaw 23
Brooklyn 22
San Mateo 22
Moscow 21
Nanchang 21
São Paulo 20
Tokyo 20
Helsinki 18
Dong Ket 17
Chennai 15
Denver 15
Milan 15
Toronto 15
Brussels 13
Frankfurt am Main 13
Johannesburg 13
Orem 13
Central 12
Falls Church 12
Naples 12
Ancona 11
Cairo 11
Lappeenranta 11
Mexico City 11
Phoenix 11
Seattle 11
Shenyang 11
Amsterdam 10
Ankara 10
Jiaxing 10
Tianjin 10
Chicago 9
New Delhi 9
Seoul 9
Ascoli Piceno 8
Boston 8
Poplar 8
San Francisco 8
Shanghai 8
Stockholm 8
Da Nang 7
Kunming 7
London 7
Manchester 7
Baku 6
Changsha 6
Düsseldorf 6
Haiphong 6
Jinan 6
Redwood City 6
Falkenstein 5
Hangzhou 5
Hebei 5
Hải Dương 5
Jundiaí 5
Melbourne 5
Nairobi 5
Norwalk 5
Prato 5
Totale 4.731
Salva come PNG Salva come JPEG
Nome #
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 207
Establishment and long-term culture of human cystic fibrosis endothelial cells 195
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 195
Mechanisms of endothelial cell dysfunction in cystic fibrosis 182
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 171
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 165
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 160
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. 159
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 158
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 152
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 151
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 148
Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. 143
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 141
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 141
Epigenetic regulation of the formyl peptide receptor 2 gene 141
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 141
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 140
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 138
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 136
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 136
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 135
Lipoxins, resolvins, and the resolution of inflammation 134
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. 132
Lipoxin receptors 132
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. 130
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 130
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. 129
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 129
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 126
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 125
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 122
Homocysteine modulates the CD40/CD40L system 121
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 121
Novel anti-inflammatory--pro-resolving mediators and their receptors. 119
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 119
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. 116
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 114
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 111
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 110
Targeting caveolin-1 deficiency in bone marrow derived cells: A new therapeutic window for fibrotic diseases? 103
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 101
RESOLVINS, LIPOXINS, AND MARESINS IN RESOLUTION OF INFLAMMATION 100
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 99
The Resolution Approach to Cystic Fibrosis Inflammation 99
Resolvin D1 and its GPCRs in resolution circuits of inflammation. 96
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 95
17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease 94
Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. 94
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 90
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 88
Impaired pro-resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease 86
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 85
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. 77
Specialized pro-resolving lipid mediators and resolution of viral diseases 76
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis 75
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 75
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 72
Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease 68
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer 66
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy 66
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment 66
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis 65
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis 65
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 64
Nrf2 Plays a Key Role in Erythropoiesis during Aging 49
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES 43
17(R)-Resolvin D1 protects against sickle cell-related inflammatory cardiomyopathy in humanized mice 8
Development and application of a multimatrix LC-MS/MS method for quantifying elexacaftor-tezacaftor-ivacaftor: Expanding therapeutic drug monitoring in cystic fibrosis from systemic circulation to airways and sweat 7
The diadenosine tetraphosphate hydrolase ApaH contributes to Pseudomonas aeruginosa pathogenicity 1
Totale 7.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.509
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 46 15 31
2021/2022344 5 10 2 88 15 11 6 22 19 15 26 125
2022/2023958 72 133 61 105 88 170 49 64 146 12 32 26
2023/2024649 54 32 37 26 35 193 97 55 7 29 19 65
2024/20251.408 74 241 147 53 85 68 90 106 122 83 155 184
2025/20262.622 254 99 236 351 309 169 548 128 309 219 0 0
Totale 7.828